Regulatory Affairs Certification (RAC) – Devices Practice Exam

These questions are part of the practice quiz. Start practicing

• What are the essential components of a Regulatory Strategy?
• What agency is primarily responsible for regulating medical devices in the U.S.?
• The QSR calls for the manufacturer of finished devices to carry out all of the following EXCEPT:
• What is the purpose of a 510(k) submission?
• If the FDA sends a warning letter regarding the mislabeling of a medical device, who should the regulatory affairs professional contact first?
• What typically defines the "level of scientific proof" required in regulatory submissions?
• What is the term for the removal of a product from the market for reasons not subject to legal action by the FDA?
• Define ‘Adverse Event’ in the context of medical devices.
• If a device failure is linked to improper use by the end user, what is a typical outcome?
• During a monitoring visit, the sponsor discovers that an investigator had used a device in a clinical investigation without obtaining informed consent from the subject. Which of the following should the regulatory affairs professional do?
• How often must a Quality Management System (QMS) be audited for compliance with ISO 13485?
• Which one of the following statements is NOT true with respect to both INDs and IDEs for significant-risk products?
• Which factor is crucial for ensuring successful regulatory approval?
• What are "Clinical Trials" in the context of medical device approval?
• In regulatory affairs, what is the significance of 'technical documentation'?
• What phase follows regulatory approval in the medical device life cycle?
• Which of the following manufacturers must register their manufacturing facility with FDA?
• Why is substantial equivalence critical in the context of 510(k) submissions?
• In regulatory affairs, what is a design dossier?
• What differentiates a medical device from a drug?
• In terms of regulatory compliance, what is the focus of a Class II medical device?
• After modifying your device with a special 510(k), when would you need to create a new listing?
• Which regulation governs the production and marketing of medical devices in the United States?
• What type of information is included in a device's declaration of conformity?
• How can a component manufacturer make critical information available to the FDA for review without revealing proprietary information to the finished product manufacturer?
• What is the primary purpose of a traditional 510(k) submission?
• What does the term 'manufacturing site' refer to?
• Which class of devices typically requires the least regulatory control?
• What does the abbreviation "RandD" stand for in the context of medical device development?
• What is the primary focus of Good Manufacturing Practices (GMP)?
• What can unaligned regulatory practices complicate in device approval?
• What role does "biological safety testing" serve in device development?
• How does regulatory convergence benefit international trade?
• If a company seeks to make a significant change to its device's fundamental scientific technology, how should this change be filed with the FDA?
• What role does the Clinical Evaluation Report (CER) play in the approval process?
• Which factors influence the classification of a medical device?
• According to the Quality System Regulations, re-testing and re-evaluation of nonconforming devices after rework activities must be documented in the:
• What does the Quality System Regulation (QSR) for medical devices (21CFR 820) pertain to?
• Which device documentation identifies all changes made throughout the product lifecycle?
• Which aspect is NOT typically included in a regulatory strategy?
• What element is crucial for effective communication with regulatory authorities?
• How do regulatory bodies assess the safety of a medical device post-market?
• Which can be considered a long-term consequence of insufficient evidence in regulatory submissions?
• What type of data is crucial from device trials and studies for regulatory submissions?
• What is the purpose of an IDE (Investigational Device Exemption)?
• In a 510(k) submission, what does 'predicate device' refer to?
• In regulatory terms, what is a potential outcome of non-compliance with safety standards?
• Which division would have primary jurisdiction over a vascular graft with an antibiotic based on primary mode of action?
• What significant change did the Medical Device User Fee and Modernization Act of 2002 enact?
• What is involved in 'risk management' within regulatory affairs for medical devices?
• What is the purpose of clinical trials in the context of medical devices?
• What is meant by "labeling" in the medical device regulatory context?
• What does FDA stand for?
• Which is a common reason for the rejection of a 510(k) submission by the FDA?
• What is a PMA application?
• What is a Class I device according to FDA classification?
• Which of the following devices would not typically require a 510(k) submission?
• What is a common component of the medical device life cycle?
• What does the term "substantially equivalent" refer to in a regulatory context?
• What might constitute a significant change requiring regulatory re-evaluation of a medical device?
• What is required for a Class II medical device before entering the market?
• According to the QSR, what is NOT a requirement for the record of a complaint investigation?
• In regulatory pathways, what does "NDA" stand for?
• Define the term "predicate device" in the context of the 510(k) process.
• What is typically required for a device to be considered "substantially equivalent" in a 510(k) submission?
• What does standard deviation assess in the context of quality control?
• What is the purpose of ISO 13485?
• What is a primary consideration in the intended use of a medical device?
• Under 21 CFR 812, the IDE regulation, which of the following statements is FALSE?
• What are the primary components of a Quality Management System (QMS)?
• What type of evidence is considered acceptable for device performance claims?
• What does the term "design controls" entail in a medical device's lifecycle?
• What does the term “de novo classification” refer to?
• How is a "clinical trial" defined concerning medical devices?
• What is the significance of a premarket notification [510(k)] in the regulatory process?
• What is one primary benefit of classifying medical devices?
• Which regulation is NOT part of the establishment, performance and auditing of a human-use clinical device trial?
• What are "user fees" in the context of FDA medical device regulations?
• The initial importer of a medical device MUST:
• When preparing a PMA, what is the significance of compliance with regulatory expectations?
• Which medical device would NOT be reviewed by CDRH's Office of Device Evaluation under 510(k) Premarket Notifications?
• What does an FDA recall entail?
• What does a Design History File (DHF) inclusive of manufacturing processes demonstrate?
• Under the official definition of a "device", which of the following is NOT considered a device?
• What is the meaning of "regulatory convergence"?
• What does "post-market surveillance" refer to in medical device regulation?
• Which organization sets international standards for the medical device industry?
• What is the aim of the "Harmonized Standards" in the EU regulatory framework?
• What are the requirements for labeling medical devices in the US?
• What does "risk assessment" primarily involve when evaluating medical devices?
• What is a 'field safety corrective action' (FSCA)?
• What is the purpose of risk management in medical device development?
• Which of the following is essential when preparing a Design History File (DHF)?
• What is the primary function of the FDA's Office of Device Evaluation?
• Pre-market Notification Requirements apply to a device that is what?
• In which class of devices is a premarket approval (PMA) required?
• What is the main purpose of labeling reviews conducted by regulatory authorities?
• What key information is typically required in a 510(k) submission?
• What is the role of the Regulatory Affairs professional in the device lifecycle?
• What does the acronym ISO stand for in the context of medical device regulations?
• What does the acronym FDA stand for?
• If a patient was hospitalized with acute sepsis after treatment with a device, how soon must the manufacturer report the event to the FDA?
• What document must manufacturers maintain to ensure compliance with FDA regulations?
• What does the FDA require from manufacturers regarding device safety?
• Which of the following is NOT required to be prepared by a regulatory affairs professional prior to submitting a PMA to the FDA?
• Which of the following requirements does NOT apply to all Class I medical devices?
• What is the definition of 'Essential Requirements' (ER) in medical device regulations?
• What are the three main classes of medical devices defined by the FDA?
• What is the main purpose of regulatory affairs in the medical device industry?
• What is the primary focus of the risk management process in medical devices?
• What is a “Not Substantially Equivalent” (NSE) determination?
• In a premarket submission, a device that is used as a comparison is referred to as what?
• What is required for a device to receive permission for clinical investigations?
• Which of the following is NOT a key Medical Device submission that directly leads to marketing permission from the FDA?
• What does the term "Adverse Event" refer to in the context of medical devices?
• Which group is NOT required to notify the FDA of information required to be reported under MDR regulations?
• At the completion of a review of a 510(k), what action may the FDA NOT take?
• What must be obtained before initiating a clinical investigation for a medical device?
• In a Non-Significant Risk device clinical trial, which of the following is NOT required before starting the trial?
• If a firm distributes a Class III device without an approved PMA, what is the statutory violation?
• What ongoing phase monitors the performance of devices after they have been launched?
• What is required for the approval of a medical device that represents a significant change in technology?
• Failure to meet 510(k) requirements for a device in commercial distribution is considered what type of statutory violation?
• When can the company's new suture, which now dissolves in the same time frame as a competitor's, be marketed?
• What is the primary purpose of regulatory affairs in the medical device industry?
• What is the meaning of "substantial equivalence" in the context of medical devices?
• What is the purpose of an ‘intended use’ statement for medical devices?
• Which agency is primarily responsible for regulating medical devices in the United States?
• What must be demonstrated for a medical device to receive market approval?
• A manufacturer which of the following must file an IDE before conducting a human clinical study?
• What is the purpose of the PMA process?
• Which section of the FDA website provides information about medical device recalls?
• Describe the concept of "benefit-risk assessment" in regulatory affairs.
• What is meant by “market authorization”?
• Which of the following is not indicative of a device being 'substantially equivalent'?
• What is primarily ensured by the review of device labeling by regulatory bodies?
• Which of the following statements about 3rd party establishment inspections under MDUFMA is NOT true?
• How does regulatory authority review of device labeling impact user safety?
• What is the significance of conducting device trials and studies?
• What type of device is typically required to undergo the 510(k) process?
• What is "concurrence" in FDA submissions?
• Which type of supplement would be used if a device undergoes a labeling change that enhances safety?
• Which of the following describes a key aspect of Good Manufacturing Practices (GMP)?
• Which classification requires the highest level of regulatory control?
• What does the term 'labeling' encompass in the context of medical devices?
• What is the purpose of device classification in regulatory terms?
• Define the term "biocompatibility" as it relates to medical devices.
• What is the significance of clinical data in a Clinical Evaluation Report (CER)?
• What is a "foreign clinical study"?
• What is a major difference between an HDE and a PMA application?
• What does the term "post-market surveillance" refer to?
• What is a key role of regulatory affairs in the medical device industry?
• What is the main purpose of a "Technical File" in device regulation?
• Which of the following subsystems is NOT required by FDA in order to implement and maintain a Quality System?
• Why is the concept of "substantial equivalence" important in regulatory affairs?
• As the Director of Regulatory Affairs at a contract sterilizer, what should you do if you find no device listing forms for sterilized devices?
• What is the primary aim of the Medical Device Regulation (MDR) in the EU?
• What does "suitable quality of evidence" mean in a regulatory context?
• What can be the consequence of significant changes in a medical device?
• During which phase of the medical device life cycle does market launch occur?
• What is an "EU Declaration of Conformity"?
• Which condition might lead to a field recall action?
• What is a Post-Market Surveillance (PMS) plan?
• What is the role of labeling claims for medical devices?
• What is the role of the European Medicines Agency (EMA) with respect to medical devices?
• What is the first option for a company if a device is declared NSE by the FDA?
• Which Congressional Act provided Statutory Authority to FDA to regulate medical devices?
• What does the term "intended use" refer to in regulatory affairs?
• A company wants to modify its legally marketed device such that the modification does not affect the intended use or alter the fundamental scientific technology. How should this change be filed?
• What can the FDA do if a device is found to pose an unreasonable risk?
• What is the purpose of risk-benefit analysis in medical device approval?
• What is a risk analysis?
• What is the role of the FDA in medical device regulation?
• What is one way to measure the appropriateness of evidence provided in submissions?
• What does a De Novo application allow for?
• When design validation activities are being performed by a manufacturer, which element is NOT included as a requirement under device design validation section of the QSR?
• What is the principle behind Good Manufacturing Practices (GMP)?
• Which of the following represents the common life cycle of a medical device?
• What does the term "marketing authorization" signify in the medical device sector?
• What is the role of a regulatory affairs professional in the medical device sector?
• How often must a device establishment registration be renewed?
• What does the term "predicate device" mean?
• For a new analyzer of an approved PSA test with no new clinical data, what PMA supplement is required?
• Which of the following is exempt from GMP/QSR regulations?
• What does 'surveillance' mean in the context of post-market medical device activities?
• What is the purpose of the ISO 13485 standard?
• What must be included in the labeling of medical devices according to FDA regulations?
• A handling and storage system for medical devices must include which of the following?
• What should manufacturers do in response to a report of adverse effects not included in a device package insert?
• What occurs during preclinical testing in the medical device life cycle?
• What do "Labeling Requirements" generally entail for Class III medical devices?
• What is the consequence of distributing a Class III device without PMA approval?
• How does a humanitarian device exemption differ from a traditional PMA?
• Under MDUFMA, FDA-accredited persons are authorized to inspect qualified manufacturers of which class of devices?
• In the context of medical device regulation, how is "safety" typically defined?
• To avoid product quality deficiencies, what should a supplier provide to the manufacturer?
• For which of the following activities is an MDDF used?
• What is the role of the European Medicines Agency (EMA) regarding medical devices?
• What distinguishes a 510(k) submission from a PMA submission?
• What does the term ‘substantial equivalence’ indicate in relation to medical devices?
• What are the three classes of medical devices as categorized by the FDA?
• What is the significance of the 'Unique Device Identification' (UDI) system?
• What is the main purpose of post-market surveillance?
• What does a CE mark signify for medical devices in the EU?